Table 3.

 Outcome of infants infected with a single pathogen.

Variable	Age
	<3 months					3–12 months
	RSV (n = 30)	Influenza (n = 3)	hCoVs (n = 3)	hMPV (n = 1)	Bocavirus (n = 1)	RSV (n = 22)	Mycoplasma pneumoniae (n = 1)
Treatment, no. (%)
Bronchodilators	30 (100.0)	3 (100.0)	3 (100.0)	1 (100.0)	1 (100.0)	22 (100.0)	1 (100.0)
Steroids	8 (26.7)	1 (33.3)	0 (0.0)	0 (0.0)	1 (100.0)	8 (36.4)	0 (0.0)
Antibiotics	16 (53.3)	2 (66.7)	1 (33.3)	0 (0.0)	0 (0.0)	7 (31.8)	1 (100.0)
Intravenous fluids	20 (66.7)	0 (0.0)	2 (66.7)	0 (0.0)	0 (0.0)	11 (50.0)	0 (0.0)
Supplemental oxygen	10 (33.3)	0 (0.0)	2 (66.7)	0 (0.0)	0 (0.0)	2 (9.1)	0 (0.0)
Chest physiotherapy	3 (10.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	2 (9.1)	0 (0.0)
Duration of hospitalization, mean days ± SD	5.96 (2.43)	5.0 (1.0)	5.33 (1.15)	4.0	5.0	5.47 (2.15)	6.0
Recurrent wheezing in the following 6 months, no. (%)
At least one episode	18 (60.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	14 (63.6)	0 (0.0)
More than one episode	3 (10.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	3 (13.6)	0 (0.0)

RSV, respiratory syncytial virus; hCoVs, human coronaviruses; hMPV, human metapneumovirus. There were no significant differences between the pathogens or age groups.